Eric Lindquist
Algemeen Directeur bij InnoSIGN BV
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Paul van de Wiel | M | - |
InnoSIGN BV
InnoSIGN BV Miscellaneous Commercial ServicesCommercial Services InnoSIGN BV is a company based in Eindhoven, Netherlands that is passionate about bringing their oncosignal pathway activity profiling technology to the market. The Dutch company's technology aims to contribute to a better understanding of disease mechanisms in oncology and enable next generation precision medicine by translating molecular data into functional cell behavior. The company was founded by Paul van de Wiel and he has been the CEO since incorporation. | - |
Richard Buller | M | 74 | 5 jaar | |
Allan W. May | M | - |
InnoSIGN BV
InnoSIGN BV Miscellaneous Commercial ServicesCommercial Services InnoSIGN BV is a company based in Eindhoven, Netherlands that is passionate about bringing their oncosignal pathway activity profiling technology to the market. The Dutch company's technology aims to contribute to a better understanding of disease mechanisms in oncology and enable next generation precision medicine by translating molecular data into functional cell behavior. The company was founded by Paul van de Wiel and he has been the CEO since incorporation. | 2 jaar |
Igor Gorbatchevsky | M | - | 3 jaar | |
Mark Mannebach | M | - | 2 jaar | |
Bernhard Lampert | M | - | 3 jaar | |
John R. MacDonald | M | - | 3 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Arthur P. DeCillis | M | 68 | - | |
Sheri Smith | F | - | - | |
Marie DeGayner Kuker | F | - | - | |
Jill Krause | F | - | 1 jaar | |
Anke Pierik | M | - |
InnoSIGN BV
InnoSIGN BV Miscellaneous Commercial ServicesCommercial Services InnoSIGN BV is a company based in Eindhoven, Netherlands that is passionate about bringing their oncosignal pathway activity profiling technology to the market. The Dutch company's technology aims to contribute to a better understanding of disease mechanisms in oncology and enable next generation precision medicine by translating molecular data into functional cell behavior. The company was founded by Paul van de Wiel and he has been the CEO since incorporation. | - |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 9 | 75.00% |
Nederland | 3 | 25.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Eric Lindquist
- Persoonlijk netwerk